These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 12110118)

  • 1. Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases.
    Bach JF
    Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S3-15. PubMed ID: 12110118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice.
    Yagi H; Matsumoto M; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Eur J Immunol; 1992 Sep; 22(9):2387-93. PubMed ID: 1516628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific antigen vaccination to treat autoimmune disease.
    McDevitt H
    Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14627-30. PubMed ID: 15466699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-alpha/beta T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice.
    Sempé P; Bédossa P; Richard MF; Villà MC; Bach JF; Boitard C
    Eur J Immunol; 1991 May; 21(5):1163-9. PubMed ID: 1828030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to DDT metabolite p,p'-DDE increases autoimmune type 1 diabetes incidence in NOD mouse model.
    Cetkovic-Cvrlje M; Olson M; Schindler B; Gong HK
    J Immunotoxicol; 2016; 13(1):108-18. PubMed ID: 25721050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmacytoid dendritic cells in autoimmune diabetes - potential tools for immunotherapy.
    Nikolic T; Welzen-Coppens JM; Leenen PJ; Drexhage HA; Versnel MA
    Immunobiology; 2009; 214(9-10):791-9. PubMed ID: 19628297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Principles of immunotherapy in insulin-dependent diabetes mellitus].
    Bretzel RG
    Wien Klin Wochenschr; 1988 Jun; 100(13):435-42. PubMed ID: 3043913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune Diabetes: An Overview of Experimental Models and Novel Therapeutics.
    You S; Chatenoud L
    Methods Mol Biol; 2016; 1371():117-42. PubMed ID: 26530798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell regulation in murine and human autoimmune diabetes: the role of TH1 and TH2 cells.
    Heurtier AH; Boitard C
    Diabetes Metab; 1997 Nov; 23(5):377-85. PubMed ID: 9416429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
    You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases.
    Alyanakian MA; You S; Damotte D; Gouarin C; Esling A; Garcia C; Havouis S; Chatenoud L; Bach JF
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15806-11. PubMed ID: 14673094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
    Pop SM; Wong CP; He Q; Wang Y; Wallet MA; Goudy KS; Tisch R
    Diabetes; 2007 May; 56(5):1395-402. PubMed ID: 17317763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes intervention therapy.
    Maclaren NK
    J Diabetes Complications; 1993; 7(2):151-6. PubMed ID: 8518457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model.
    Toyoda H; Formby B
    Bioessays; 1998 Sep; 20(9):750-7. PubMed ID: 9819564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early intervention in insulin-dependent diabetes mellitus.
    Cahill GF
    Curr Probl Clin Biochem; 1983; 12():108-18. PubMed ID: 6418442
    [No Abstract]   [Full Text] [Related]  

  • 17. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes.
    Jarpe AJ; Hickman MR; Anderson JT; Winter WE; Peck AB
    Reg Immunol; 1990-1991; 3(6):305-17. PubMed ID: 2132756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NOD mouse: a model of immune dysregulation.
    Anderson MS; Bluestone JA
    Annu Rev Immunol; 2005; 23():447-85. PubMed ID: 15771578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse.
    Giarratana N; Penna G; Adorini L
    Methods Mol Biol; 2007; 380():285-311. PubMed ID: 17876100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.